An interventional study of Reiki Group and Sham Reiki Group in Diabetic Neuropathy, sponsored by TC Erciyes University. Recruiting at 1 site in Turkey. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2025-02-14.
Sponsored by TC Erciyes University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 28 studies in Diabetic Neuropathies with a site in Turkey — 6 open to participants now, 7 under way, none of them phase 3. Diabetic Neuropathies · Turkey.
Among the 28 studies in Diabetic Neuropathies with a site in Turkey, this one is the 8th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2024, is one of 18 with no phase, and was the 15th registered.
539 studies on the registry are indexed under Diabetic Neuropathies; 80 are open to participants now.
Browse Diabetic Neuropathies studies →6 of the 28 studies in Diabetic Neuropathies with a site in Turkey are open now. Recruiting first, the newest first:
Nurgül Gün · Sites in Turkey
Ages 18–70
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Healthy volunteers
GÜLDEN ANATACA · Sites in Turkey
Ages 30–75 · Healthy volunteers
Fatih Sultan Mehmet Training and Research Hospital · Sites in Turkey
Ages 18+ · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40–75
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 52 Diabetic Neuropathies studies recruiting now, 21 (40%) set no upper age limit and 24 (46%) stop at 75 or younger; 6 take children under 18; 3 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
28 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 68 across 449 interventional studies indexed under Diabetic Neuropathies.
Median enrollment 49 across the 20 interventional studies, 85 across the 8 observational. Of the 21 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 28 have an industry lead sponsor. The 10 most frequent:
TC Erciyes University is the lead sponsor of 350 studies on the registry; 73 are open to participants now.
TC Erciyes University has 1 study filed under Diabetic Neuropathies — fewer than ten, so there is no comparison to draw.
1 of the studies in Diabetic Neuropathies with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07702175Nurgül GünEffect of 4-7-8 Breathing Technique on Pain and Anxiety During Electromyography in Diabetic Neuropathy | 2027-02-15 |
Add it to your calendar (.ics) → With an account.
Among the 28 studies in Diabetic Neuropathies with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The study is planned to be conducted in a mixed research design with quantitative and qualitative types. The quantitative phase of the study was planned as a single-blind, randomized controlled study with Reiki group, Sham Reiki group and control group designs in order to examine the effect of second-level (remote application) Reiki applied to patients with diabetic neuropathy for 20 minutes a day for four days on pain intensity, neuropathic pain intensity (DN4 Questionnaire) total scores and sleep quality. The qualitative study will be conducted with 4 people from the Reiki and Sham Reiki groups, a total of 8 patients, one week after the application, using the individual in-depth interview method and a semi-structured questionnaire.
Research hypotheses;
H01: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has no effect on reducing pain intensity.
H11: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has an effect on reducing pain intensity.
H02: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has no effect on reducing neuropathic pain intensity.
H12: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has an effect on reducing neuropathic pain intensity.
H03: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has no effect on sleep quality.
H13: Second-level Reiki applied to patients with diabetic neuropathy for 20 minutes once a day for 4 days has an effect on sleep quality.
Reiki/Sham Reiki Application Protocol After the assignment of patients with diabetic neuropathy to the groups by lot, the Reiki group will be applied remotely by a researcher who has received second-level training, and the Sham Reiki group will be applied remotely by a nurse who is not a Reiki practitioner trained by the researcher and has not received any training before, in accordance with the application protocol.
Research Groups Intervention Group-1 A 20-minute remote Reiki application will be applied once a day for four days by a researcher who has received second-level training. No changes will be made to the standard treatment plan of the patients during the application.
Intervention Group-2 A 20-minute remote Sham Reiki application will be applied once a day for four days by a nurse who has not received Reiki training and has not been initiated. No changes will be made to the standard treatment plan of the patients during the application.
Control Group No application will be applied to the patients for four weeks. Individuals will continue to receive their normal treatments.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Remote Reiki application will be performed once a day for 20 minutes for four days by a researcher who has received second-level training.
Other: Reiki Group
In the placebo group, the Sham Reiki group will receive remote Reiki application in accordance with the application protocol by a nurse who is not a Reiki practitioner trained by the researcher and has not received any previous training.
Other: Sham Reiki Group
For four weeks, patients will not receive any treatment. Individuals will continue to receive their normal treatments.
Remote Reiki application will be performed once a day for 20 minutes for four days by a researcher who has received second level training. No changes will be made to the standard treatment plan of the patients during the application.
In the placebo group, the Sham Reiki group will receive remote Reiki application in accordance with the application protocol by a nurse who is not a Reiki practitioner trained by the researcher and has not received any previous training.
Visual Analog Scale(VAS)
The value of "0 points" in the scale, which indicates the absence of pain, indicates a good condition, and the maximum value, "10 points", indicates a bad condition with unbearable pain intensity.
Time frame: Pre-test data will be collected before starting the study and post-test data will be collected 1 week later.
McGill Pain Scale - Short Form
The scale form provides information on the sensory intensity, size and perceived effects of pain. In this respect, the scale consists of three dimensions. The first dimension includes 15 items that define the quality of pain. 11 of the items are sensory and 4 determine the perceptual dimension of pain. The intensity of pain is indicated in the items by grading between 0-3 (0=none, 1=mild, 2=moderate, 3=excessive). In the first dimension, the perceptual pain score is evaluated between 0-12, the sensory pain score is evaluated between 0-33 and the total pain score is evaluated between 0-45. An increase in the total score indicates an increase in the pain level. In the second dimension, the intensity of pain felt by the individual is determined by five expressions ranging from "mild pain" to "unbearable pain". In the third dimension, the individual's instant intensity is compared visually. The scale is listed in 0-5 points options. Minimum ''0=point, no pain; Indicates good condition.
Time frame: Pre-test data will be collected before starting the study and post-test data will be collected 1 week later.
4 Question Neuropathic Pain Questionnaire (DN4)
The first two questions are based on interviews with the patient; The first question is about the definition of pain (tingling, burning, cold), and the second question is; It is related to paresthesia and dysesthesia (numbness, prickling, tingling and itching) in the painful area. The third question examines sensory disturbances (needling, touch and hypoesthesia) in the area where the pain is localized, and the fourth question; It determines whether friction causes an increase in the presence and severity of pain. Each question is scored as "yes answer = 1 point" or "no answer = 0 point". A minimum score of 4 points and above indicates neuropathic pain. Indicates a bad situation. A maximum score of 10 is taken from the scale. This indicates that the pain is severe and worse.
Time frame: Pre-test data will be collected before starting the study and post-test data will be collected 1 week later.
Pittsburgh Uyku Kalitesi Endeksi PUKI
Each item is evaluated between 0-3 points. The scale consists of 7 subcomponents that evaluate objective sleep quality (component 1), sleep latency (component 2), sleep duration (component 3), sleep habits, sleep disorders, sleeping pill use (component 5, component 6) and loss of daytime functionality. The sum of these components is the PSQI score. It indicates that sleep disturbance is severe in at least two of the 7 components or moderate in three component areas. A minimum score of 0-5 on the scale indicates that sleep quality is good. 5 points and above indicate that sleep quality is poor. Maximum scale total score It is 21 points.
Time frame: Pre-test data will be collected before starting the study and post-test data will be collected 1 week later.
Plan to share: No — Once the study is completed, its results will be shared with other researchers once the study data is published.
No publications or documents are linked to this record.
Started Nov 2024 (actual). Primary completion is estimated for May 2025, 6 months after the start.
Of 138 non-industry interventional studies with no phase under Diabetic Neuropathies, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 24. This study's planned 6 months is below that.
Counting every sponsor, half of 153 studies reached it within 11 months; a quarter within 6 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.